Identification of genes that predict the response to chemotherapy with 5-azacytidine in myelodysplastic syndromes

被引：0
|
作者：
Matsumoto, Taichi [1 ,2 ]
Murakami, Yuichi [1 ]
Katsuchi, Daisuke [1 ]
Kuwano, Michihiko [1 ]
Ono, Mayumi [1 ,3 ]
机构：
[1] St Marys Inst Hlth Sci, Canc Transl Res Ctr, Fukuoka, Japan
[2] Fukuoka Univ, Dept Drug Inform, Pharm Sci, Fukuoka, Japan
[3] St Marys Coll, Grad Sch Nursing, Dept Pharm Oncol, Fukuoka, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2366
引用
收藏
页码：1261 / 1261
页数：1
相关论文
共 50 条
  • [41] Key clinical observations after 5-azacytidine and decitabine treatment of myelodysplastic syndromes suggest practical solutions for better outcomes
    Saunthararajah, Yogen
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 511 - 521
  • [42] The Association of ASXL1 and ZRSR2 Mutations with Response to the Combination of Alvocidib and 5-Azacytidine in Patients with High-risk myelodysplastic Syndromes
    Riabov, V
    Xu, Q.
    Schmitt, N.
    Streuer, A.
    Jann, J-C
    Wein, A.
    Altrock, E.
    Mehralivand, A.
    Nowak, V
    Weimer, N.
    Oblaender, J.
    Palme, I
    Jawhar, A.
    Darwich, A.
    Wuchter, P.
    Weiss, C.
    Metzgeroth, G.
    Foulks, J. M.
    Steiner, L.
    Jawhar, M.
    Hofmann, W-K
    Nowak, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 37 - 37
  • [43] SEVERE RENAL TUBULAR DYSFUNCTION DURING 5-AZACYTIDINE CHEMOTHERAPY
    COLLINS, AJ
    VOGELZANG, NJ
    BLOOMFIELD, CD
    PETERSON, BA
    CLINICAL RESEARCH, 1979, 27 (04): : A708 - A708
  • [44] CHEMOTHERAPY FOR MALIGNANT MESOTHELIOMA WITH ADRIAMYCIN AND CONTINUOUS INFUSION OF 5-AZACYTIDINE
    CHAHINIAN, AP
    HOLLAND, JF
    MANDEL, EM
    CANCER TREATMENT REPORTS, 1978, 62 (07): : 1108 - 1109
  • [45] Transcriptomic profiling of Aspergillus flavus in response to 5-azacytidine
    Lin, Jian-Qing
    Zhao, Xi-Xi
    Zhi, Qing-Qing
    Zhao, Ming
    He, Zhu-Mei
    FUNGAL GENETICS AND BIOLOGY, 2013, 56 : 78 - 86
  • [46] ACTIVATION AND DEMETHYLATION OF THE INTRACISTERNAL-A PARTICLE GENES BY 5-AZACYTIDINE
    DAVIS, CM
    CONSTANTINIDES, PG
    VANDERRIET, F
    VANSCHALKWYK, L
    GEVERS, W
    PARKER, MI
    CELL DIFFERENTIATION AND DEVELOPMENT, 1989, 27 (02): : 83 - 93
  • [47] Safer management of the 5-azacytidine administration in domiciliary care in patients with myelodysplastic syndrome
    Alarcon-Payer, C.
    Jimenez Morales, A.
    Garcia Collado, C.
    Garcia Fumero, R.
    Jurado Chacon, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 332 - 333
  • [48] Is it time for 5-azacytidine combinations in high-risk myelodysplastic syndrome patients?
    Park, Sophie
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (01) : 39 - 42
  • [49] Identification of mutations conferring 5-azacytidine resistance in bacteriophage Qβ
    Arribas, Maria
    Cabanillas, Laura
    Lazaro, Ester
    VIROLOGY, 2011, 417 (02) : 343 - 352
  • [50] Efficacy of Frontline 5-Azacytidine in Older AML Patient Unfit for Chemotherapy
    Bories, Pierre
    Bertoli, Sarah
    Huguet, Francoise
    Dobbelstein, Sophie
    Fornecker, Luc
    Rauzy, Odile Beyne
    Demas, Veronique
    Berceanu, Ana
    Delabesse, Eric
    Recher, Christian
    BLOOD, 2011, 118 (21) : 1122 - 1122
12345